0001264124-12-000077.txt : 20120302 0001264124-12-000077.hdr.sgml : 20120302 20120302194541 ACCESSION NUMBER: 0001264124-12-000077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120301 FILED AS OF DATE: 20120302 DATE AS OF CHANGE: 20120302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOLETTA MARK G CENTRAL INDEX KEY: 0001236389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 12664525 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2012-03-01 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001236389 FOLETTA MARK G 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 0 1 0 1 SVP, Chief Financial Officer SVP, Chief Financial Officer Common Stock 2012-03-01 4 S 0 1846 17.11 D 62490 D Common Stock 3868.2 I Indirect-401k Common Stock 6445.1 I by ESOP Common Stock 110 I by wife Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of restricted stock units. Includes 897 shares recently acquired under the Company's Employee Stock Purchase Plan. These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment. The reporting person acquired beneficial ownership of these shares in November, 2007. By: /s/ Attorney-in-Fact, James R. Oehler For: Mark G. Foletta 2012-03-02